Skip to main content
SpringerLink
Log in

Peripheral Blood Mononuclear Cell DNA 6-Thioguanine Metabolite Levels Correlate with Decreased Interferon-γ Production in Patients with Crohn's Disease on AZA Therapy

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

6-Mercaptopurine (6-MP) and its prodrug azathioprine (AZA) are well known for their lymphocytotoxic and bone marrow suppressive effects in the management of patients with leukemia. Although their immunosuppressive properties are mediated by the active AZA antimetabolite 6-thioguanine (6-TG), its mechanism of action is largely unknown. In IBD, a significant inverse correlation has been shown between erythrocyte 6-TG metabolite levels and disease activity, further supporting the proposed immunosuppressive role for 6-TG. Since leukocytes possess quantitatively different purine metabolic pathways compared to erythrocytes, this study aims to measure lymphocyte DNA 6-TG metabolites and correlate levels with the INF-γ and IL-10 cytokine profile in patients with Crohn's disease (CD). Forty-six adult patients with CD, either naive (17) or on long-term (>4-month) AZA therapy (29), had erythrocyte and lymphocyte DNA 6-TG levels measured by reverse-phase HPLC under UV detection (6-TG, 340 nm). Lymphocyte DNA 6-TG was expressed as picomoles per milligram of DNA. Lymphocyte DNA 6-TG metabolite levels were correlated with INF-γ and IL-10 cytokine profiles using the OptEIA kit (Pharmigen). Lymphocyte DNA 6-TG metabolite levels correlate with erythrocyte 6-TG levels (P < 0.03) but not total patient leukocyte levels. Erythrocyte 6-TG metabolite levels correlated (P < 0.01) inversely with INF-γ but not IL-10 cytokine levels. This study suggests a preferential dampening of the TH1 response on exposure to 6-TG and a possible immunosuppressive mechanism of action for AZA. Future studies are needed to determine if cytokine profiles can be used to predict recalcitrant CD to AZA therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Pearson DC, May GR, Fick GH, Sutherland LR: Azathioprine and 6-mercaptopurine in Crohn's disease: a meta-analysis. Ann Intern Med 122:132–142, 1995

    Google Scholar 

  2. O'Brien JJ, Bayless TM, Bayless JA: Use of azathioprine or 6-mercaptopurine in the treatment of Crohn's disease. Gastroenterology 101:39–46, 1991

    Google Scholar 

  3. Ewe K, Press AG, Singe CC, Stufler M, Ueberschaer B, Hommel G, Buschenfelde KHMZ: Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease. Gastroenterology 105:367–372, 1993

    Google Scholar 

  4. Present DH, Korelitz BI, Wisch N: Treatment of Crohn's disease with 6-mercaptopurine.Along-term, randomized, double-blind study. N Engl J Med 302:981–987, 1989

    Google Scholar 

  5. Elion GB: The pharmacology of azathioprine. Ann NY Acad Sci 21:401–407, 1977

    Google Scholar 

  6. Fairchild CR, Maybaum J, Kennedy KA: Concurrent unilateral chromatid damage and DNA strand breaks in response to 6-thioguanine treatment. Biochem Pharmacol 35:3533–3541, 1986

    Google Scholar 

  7. Christie NT, Drake S, Meyn RE: 6-Thioguanine induced DNA damage as a determinant of cytotoxicity in cultured hamster ovary cells. Cancer Res 44:3665–3671, 1986

    Google Scholar 

  8. Weinshilboum RN, Sladek Sl: Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyl transferase activity. Am J Hum Genet 32:651–662, 1980

    Google Scholar 

  9. Lennard L: The clinical pharmacology of 6-mercaptopurine in acute lymphoblastic leukemia. Eur J Clin Pharmacol 43:329–339, 1992

    Google Scholar 

  10. Lennard L, Lilleyman JS: Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia. J Clin Oncol 7:1816–1823, 1989

    Google Scholar 

  11. McLeod HL, Relling MV, Liu Q, Pui CH, Evans WE: Polymorphic thiopurine methyl transferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemia. Blood 85:1897–1902, 1995

    Google Scholar 

  12. Evans WE, Homer M, Chu YQ: Altered mercaptopurine metabolism, toxic effects, and dosage requirements in a thiopurine methyl transferase deficient child with acute lymphoblastic leukemia. J Pediatr 119:985–989, 1991

    Google Scholar 

  13. Colonna T, Korelitz B: The role of leukopenia in 6-mercaptopurine-induced remission of refractory Crohn's disease.Am J Gastroenterol 89:362–366, 1993

    Google Scholar 

  14. Tiede I, Wirtz S, Strand S, Strand D, Atreya R, Mudter J, Hildner K, Holtmann M, Bartsch B, Lehr HA, Blumberg RS, Walczak H, Galle PR, Neurath M: CD28-induced Rac-GTP activiy is the molecular target of azathioprine in primary human CD4+ T-lymphocytes: a mechanism for azathioprine mediated immunosuppression in IBD based on induction of T-cell apoptosis. Gastroenterology 122:A14, 2002

    Google Scholar 

  15. Pullman WE, Elsbury S, Kobayashi M, Hapel AJ, Doe WF: Enhanced mucosal cytokine production in inflammatory bowel disease. Gastroenterology 102:529, 1992

    Google Scholar 

  16. Nakamura M, Saito H, Kasanuki J, Tamura Y, Yoshida S: Cytokine production in patients with inflammatory bowel disease. Gut 33:933–937, 1992

    Google Scholar 

  17. Chomarat P, Rissoan MC, Banchereau J, and Miossec P: Contribution of IL-1, CD14, and CD13 in the increased IL-6 production induced by in vitro monocyte-synoviocyte interactions. J Immunol 155:3645–3652, 1995

    Google Scholar 

  18. Hibi T, Ogata H, Sakuraba A: Animal models of inflammatory bowel disease. J Gastroenterol 37:409–417, 2002

    Google Scholar 

  19. Kombluth A, Sachar DB, Salomon P: Crohn's disease. In Gastrointestinal Diseases. MH Sleisenger, JS Fordtran (eds). Philadelphia, PA, WB Saunders, 1998, pp 1708–1734

    Google Scholar 

  20. Cuffari C, Theoret Y, Latour S, Seidman EG: 6-Mercaptopurine metabolism in Crohn's disease correlation with efficacy and toxicity. Gut 39:401–406, 1996

    Google Scholar 

  21. Cuffari C, Seidman EG, Latour S, Theoret Y: Quantitation of 6-thioguanine in peripheral blood leukocyte DNA in Crohn's disease patients on maintenance 6-maintenance 6-mercaptopurine therapy. Can J Physiol Pharmacol 74:580–585, 1996

    Google Scholar 

  22. Lennard L, Rees CA, Lilleyman JS. Childhood leukemia: a relationship between intracellular 6-mercaptopurine metabolites and neutropenia. Br J Clin Pharmacol 16:359–363, 1993

    Google Scholar 

  23. Dubinsky MC, Feldman E, Abreu MT, Seidman EG, Baroni D, Kornbluth A, Targan SR, Vasiliauskas EA: Idiosyncratic adverse reactions to 6-mercaptopurine and azathioprine can be averted by switching to 6-thioguanine in patients with IBD. Gastroenterology 120:A56, 2001

    Google Scholar 

  24. Dubinsky MC, Lamothe S, Yang HY, Targan SR, Sinnett D, Theoret Y, Seidman EG: Optimizing and individualizing 6-MP therapy in IBD: The role of 6-MP metabolite levels and TPMT genotyping. Gastroenterology 118;705–713, 2000

    Google Scholar 

  25. Paterson ARP, Moriwaki A: Combination chemotherapy: synergistic inhibition of L5178Y ells in culure and in vivo with 6-mercaptopurine and 6-methyl mercapopurine ribonucleotides. Cancer Res 30:2379–2387, 1970

    Google Scholar 

  26. Mawatari H, Unei K, Nishimura S, Sakura N, Ueda K: Comparative pharmacokinetics of oral 6-mercaptopurine and intravenous 6-mercaptopurine riboside in children. Pediatr Int 43:673–677, 2001

    Google Scholar 

  27. Ansari AR, Marinaki T, Arenas M, Sumi S, Shobowale-Bakre El-M, Lewis K, Woodman I, Duley J, Sanderson J: Mutations in the ITPA gene predicts intolerance to azathioprine. Gastroenterology 124:A11, 2003

    Google Scholar 

  28. Hildner K, Marker-Hermann E, Schlaak JF, Becker C, Germann T, Schmitt E, Meyer Zum Buschenfelde KH, Neurath MF: Azathioprine, mycophenolate mofetil, and methotrexate specifically modulate cytokine production by T cells. Ann NY Acad Sci 859:204–207, 1998

    Google Scholar 

  29. Van den Berg AP, Twilhaar WN, Corver W, Geerts AB, Mesander G, Klompmaker IJ, Sloof MJH, The TH, de Leij LH: Cyclosporine A is associated with a shift of the TH1/TH2 balance in liver transplant patients. Transplant Proc 30:2378–2379, 1998

    Google Scholar 

  30. Durez P, Abramowicz D, Gerard C, Van Mechelen M, Amraoui Z, Dubois C, Leo O, Velu T, Goldman T: In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: Differential modulation by cyclosporin A J Exp Med 177:551–555, 1993

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Division of Gastroenterology and Nutrition, The Johns Hopkins University, Baltimore, Maryland, USA

    C. Cuffari, D. Y. Li, J. Mahoney & Y. Barnes

  2. Department of Medicine, The Johns Hopkins University, Baltimore, Maryland, USA

    T. M. Bayless

Authors
  1. C. Cuffari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Y. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Mahoney
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y. Barnes
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. M. Bayless
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cuffari, C., Li, D.Y., Mahoney, J. et al. Peripheral Blood Mononuclear Cell DNA 6-Thioguanine Metabolite Levels Correlate with Decreased Interferon-γ Production in Patients with Crohn's Disease on AZA Therapy. Dig Dis Sci 49, 133–137 (2004). https://doi.org/10.1023/B:DDAS.0000011614.88494.ee

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:DDAS.0000011614.88494.ee

Search

Navigation